Literature DB >> 21506163

Pupillary unrest correlates with arousal symptoms and motor signs in Parkinson disease.

Samay Jain1, Greg J Siegle, Chen Gu, Charity G Moore, Larry S Ivanco, Stephanie Studenski, J Timothy Greenamyre, Stuart R Steinhauer.   

Abstract

BACKGROUND: Arousal symptoms (e.g., sleepiness) are common in Parkinson's disease, and pupillary unrest (spontaneous changes in pupil diameter) is positively associated with sleepiness. We explored pupillary unrest in Parkinson's disease.
METHODS: Arousal symptoms (Epworth sleepiness scale and sleep/fatigue domain of the nonmotor symptoms scale for Parkinson's disease) and pupillary unrest were assessed in 31 participants (14 patients with Parkinson's disease, 17 controls). Effect sizes and t tests compared patients with Parkinson's disease with control participants. Correlation coefficients were calculated among arousal symptoms, pupillary unrest, and Unified Parkinson Disease Rating Scale Part III. Linear regression was performed with arousal symptoms or pupillary unrest as outcome.
RESULTS: Participants with Parkinson's disease reported more arousal symptoms than controls. Pupillary unrest, arousal symptoms, and Unified Parkinson Disease Rating Scale Part III were positively correlated. The association between nonmotor symptoms scale-sleep score and pupillary unrest was higher in participants with Parkinson's disease than controls and higher in those with more Parkinsonian motor signs. Unified Parkinson Disease Rating Scale Part III was positively associated with pupillary unrest.
CONCLUSIONS: Pupillary unrest correlates with motor and nonmotor features associated with Lewy-related pathology, suggesting it may be a nonmotor marker of progression in Parkinson's disease. © 2011 Movement Disorder Society.
Copyright © 2011 Movement Disorder Society.

Entities:  

Mesh:

Year:  2011        PMID: 21506163      PMCID: PMC3119728          DOI: 10.1002/mds.23628

Source DB:  PubMed          Journal:  Mov Disord        ISSN: 0885-3185            Impact factor:   10.338


  8 in total

1.  The metric properties of a novel non-motor symptoms scale for Parkinson's disease: Results from an international pilot study.

Authors:  Kallol Ray Chaudhuri; Pablo Martinez-Martin; Richard G Brown; Kapil Sethi; Fabrizio Stocchi; Per Odin; William Ondo; Kazuo Abe; Graeme Macphee; Doug Macmahon; Paolo Barone; Martin Rabey; Alison Forbes; Kieran Breen; Susanne Tluk; Yogini Naidu; Warren Olanow; Adrian J Williams; Sue Thomas; David Rye; Yoshio Tsuboi; Annette Hand; Anthony H V Schapira
Journal:  Mov Disord       Date:  2007-10-15       Impact factor: 10.338

Review 2.  Non-motor symptoms of Parkinson's disease: diagnosis and management.

Authors:  K Ray Chaudhuri; Daniel G Healy; Anthony H V Schapira
Journal:  Lancet Neurol       Date:  2006-03       Impact factor: 44.182

Review 3.  Parkinson's disease--Part 1: Pathophysiology, symptoms, burden, diagnosis, and assessment.

Authors:  Daniel Weintraub; Cynthia L Comella; Stacy Horn
Journal:  Am J Manag Care       Date:  2008-03       Impact factor: 2.229

4.  Mathematical procedures in data recording and processing of pupillary fatigue waves.

Authors:  H Lüdtke; B Wilhelm; M Adler; F Schaeffel; H Wilhelm
Journal:  Vision Res       Date:  1998-10       Impact factor: 1.886

Review 5.  Stages in the development of Parkinson's disease-related pathology.

Authors:  Heiko Braak; Estifanos Ghebremedhin; Udo Rüb; Hansjürgen Bratzke; Kelly Del Tredici
Journal:  Cell Tissue Res       Date:  2004-08-24       Impact factor: 5.249

6.  A new method for measuring daytime sleepiness: the Epworth sleepiness scale.

Authors:  M W Johns
Journal:  Sleep       Date:  1991-12       Impact factor: 5.849

7.  Quantifying the risk of neurodegenerative disease in idiopathic REM sleep behavior disorder.

Authors:  R B Postuma; J F Gagnon; M Vendette; M L Fantini; J Massicotte-Marquez; J Montplaisir
Journal:  Neurology       Date:  2008-12-24       Impact factor: 9.910

8.  The rostral mesencephalon in Parkinson's disease and Alzheimer's disease.

Authors:  S Hunter
Journal:  Acta Neuropathol       Date:  1985       Impact factor: 17.088

  8 in total
  7 in total

Review 1.  A systematic review of the literature on disorders of sleep and wakefulness in Parkinson's disease from 2005 to 2015.

Authors:  Lama M Chahine; Amy W Amara; Aleksandar Videnovic
Journal:  Sleep Med Rev       Date:  2016-08-31       Impact factor: 11.609

2.  Publication guidelines and recommendations for pupillary measurement in psychophysiological studies.

Authors:  Stuart R Steinhauer; Margaret M Bradley; Greg J Siegle; Kathryn A Roecklein; Annika Dix
Journal:  Psychophysiology       Date:  2022-04       Impact factor: 4.348

3.  Association between pupillometric sleepiness measures and sleep latency derived by MSLT in clinically sleepy patients.

Authors:  Keiko Yamamoto; Fumio Kobayashi; Reiko Hori; Aki Arita; Ryujiro Sasanabe; Toshiaki Shiomi
Journal:  Environ Health Prev Med       Date:  2013-02-19       Impact factor: 3.674

Review 4.  Pupillary motility: bringing neuroscience to the psychiatry clinic of the future.

Authors:  Simona Graur; Greg Siegle
Journal:  Curr Neurol Neurosci Rep       Date:  2013-08       Impact factor: 5.081

5.  Fatigue in Parkinson's disease: report from a mutidisciplinary symposium.

Authors:  Joseph H Friedman; James C Beck; Kelvin L Chou; Gracia Clark; Christopher P Fagundes; Christopher G Goetz; Karen Herlofson; Benzi Kluger; Lauren B Krupp; Anthony E Lang; Jao-Shin Lou; Laura Marsh; Anne Newbould; Daniel Weintraub
Journal:  NPJ Parkinsons Dis       Date:  2016-01-14

6.  Changes in pupil diameter are correlated with the occurrence of pareidolias in patients with dementia with Lewy bodies.

Authors:  Yumi Suzuki; Kazumi Hirayama; Tatsuo Shimomura; Makoto Uchiyama; Hiromi Fujii; Etsuro Mori; Yoshiyuki Nishio; Osamu Iizuka; Ryusuke Inoue; Mika Otsuki; Shinya Sakai
Journal:  Neuroreport       Date:  2017-03-01       Impact factor: 1.837

Review 7.  Retinal Degeneration: A Window to Understand the Origin and Progression of Parkinson's Disease?

Authors:  Yanyan Zhang; Xiaoguang Zhang; Yunhua Yue; Tian Tian
Journal:  Front Neurosci       Date:  2022-02-04       Impact factor: 4.677

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.